Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar

• Status: Completed
• Trial end date: 2017-02-14

Summary

The study is aimed to evaluate the analgesic efficacy of TRAM.HCl/DKP.TRIS 75mg/25mg oral fixed drug combination in comparison with TRAM.HCl /paracetamol 75mg/650mg in the treatment of moderate to severe acute pain.

• Phase: Phase 4

Details

• Lead Sponsor: Menarini Group
• Treatments: Acetaminophen; Analgesics; Dexketoprofen trometamol; Ketoprofen; Tramadol